DSIP was specifically developed to target the deep-sleep deficits that underlie many forms of chronic insomnia. Unlike sedative-hypnotics that create an induced sleep state, DSIP works by modulating the brain's own sleep regulation system to make natural, high-quality sleep more accessible.
Deep Sleep Access
Many chronic insomniacs can fall asleep but struggle to reach or stay in Stage 3 (Slow-Wave) sleep - the most restorative phase. DSIP specifically facilitates the transition into and maintenance of this stage.
Reduced Nighttime Wake-Ups
By stabilizing sleep architecture across the full night, DSIP reduces the fragmentation that leaves many patients waking at 2 or 3 a.m. and struggling to return to sleep.
No "Hangover" Effect
Because DSIP works with natural neurochemistry, patients typically wake feeling restored rather than groggy - a common complaint with prescription sleep medications.
No Dependency Risk
DSIP does not work through GABA suppression or other receptor mechanisms associated with dependence. The cycle protocol (12 weeks on, 2 weeks off) further supports sustained receptor sensitivity.
You may benefit from DSIP if you:
DSIP is not for use in patients with cancer, a history of cancer, pregnancy, or breastfeeding.
A medical assessment is required before a prescription is issued.